{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Paul Truesdell Podcast","title":"Long Wars, Long Contracts: Why Army Procurement Belongs in Your Portfolio - Part 3","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/02ea629c\"></iframe>","width":"100%","height":180,"duration":540,"description":"3Preparing Yourself—and Future Generations—for Biological and Supply-Chain RisksNow that we've envisioned that fraught moment—when calm could give way to chaos—we need to talk about one of the silent but very real vulnerabilities so many retirees face: their medicine cabinet. Medication Supply Chains: The Hidden VulnerabilityWe rely heavily on foreign sources for our medications. In fact, about 75% of essential medicines in the U.S. are imported, with India and China playing outsized roles—China alone supplies 80% of active pharmaceutical ingredients (APIs), the substances that make drugs effective.To put it in human terms: many retirees depend on life-sustaining drugs—like those for heart disease, diabetes, antibiotics—that come with three-week delivery windows. What if a crisis disrupts that pipeline?Consider this: 40% of generic drugs in the U.S. come from a single FDA-approved manufacturer.  If that plant goes offline—even momentarily—the drugs disappear from shelves. In 2024 alone, the U.S. saw an all-time high of over 300 drug shortages, affecting asthma treatments, psychiatric meds, chemotherapy—across the board.COVID-19 shone a harsh light on how fragile this system is. Factories in India and China were shuttered, production slowed, and suddenly simple items like inhalers or antibiotics were scarce.Tariffs, geopolitical tensions, or trade disputes could instantly reignite shortages—this time not from a pandemic, but from strategic moves in a global standoff. A Biological or Chemical Attack: More Than Just a Movie PlotLet’s take this farther. What if it’s not just supply disruptions—but a biological or chemical release targeting civilian or critical infrastructure?This isn’t speculation. U.S. agencies have long prepared for covert releases of pathogens—viruses, bacteria, toxins—by focusing on preparedness, surveillance, and fast diagnostics.Imagine a plane dispersing a cocktail of aerosolized agents—perhaps a DNA virus and an RNA virus—over a city’s water...","thumbnail_url":"https://img.transistorcdn.com/115-XsjkdwCpJ99xv-8oZ76t6jr8ScWEC5MYSKzL0ig/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS82MTUx/OWRiNTc0NTk0Y2Nk/M2VjYTliMGVhN2Zm/YTZkZi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}